Investor Overview

    

Corporate Profile

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cardiovascular, metabolic and liver diseases.
NASDAQ MDGL (Common)
$16.50 - 1
Stock chart for: MDGL.OQ.  Currently trading at $16.50 with a 52 week high of $18.24 and a 52 week low of $6.60.
Apr 28, 2017 3:59 p.m. ET